Dynavax Technologies Corp. Financial Ratios
DVAX / Health Care|FY2024 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2024 SEC 10-K data.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2024)
Return on Equity
4.6%
Profit Margin
9.9%
Net Income / Revenue
Asset Turnover
0.28
Revenue / Total Assets
Equity Multiplier
1.65
Total Assets / Equity
Composite: 4.6% (reported: 4.6%)
Profitability
Liquidity
Current Ratio
10.80
Quick Ratio
9.91
Solvency
Interest Coverage
9.79
Efficiency
Asset Turnover
0.28
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2024 · SEC 10-K · Updated Feb 28, 2026
Earnings Quality
Accrual Ratio
-4.0%
+6.8pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.